An observational study in Crohn Disease, sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-02-09.
Sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Observational
The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients.
A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.
Number of patients expected : at least 600, coming from all types of practices (ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice)).
Recruitment period : 1 year
Primary endpoint : The primary endpoint is the description of the factors linked to:
Secondary endpoint :
1,880 studies on the registry are indexed under Crohn Disease; 462 are open to participants now.
This study's planned enrollment of 600 is above the median of 162 across 608 observational studies indexed under Crohn Disease.
Browse Crohn Disease studies →Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives is the lead sponsor of 35 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with Crohn's disease, going to ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice) centres, who have been diagnosed within the year before the inclusion visit.
Exclusion Criteria:
A questionnaire will be completed by the participant and their gastroenterologist. Estimated completion time is 30 minutes for the patient, 10 minutes for the gastroenterologist.
Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.
Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.
Time frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.
Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.
Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.
Time frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.
Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.
Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.
Time frame: Day 1 from appearence of first symptoms and the diagnosis of the disease.
Number of predictive factors associated with a delayed diagnosis
Number of predictive factors associated with a delayed diagnosis
Time frame: Day 1
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives